Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)

Award Notice Posted

Solicitation number
75A50126C00001
Agency
Awarded
to Albert B. Sabin Vaccine Institute, Inc. (The)
Set-aside
No set-aside

Opportunity facts

Contract number
75A50126C00001 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
6505 Drugs And Biologicals
Place of performance
District of Columbia 20006, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded contract 75A50126C00001 to Albert B. Sabin Vaccine Institute, Inc. for $1,042,099,118 on May 5, 2026, for advanced development, FDA licensure, procurement, shipping, and vendor-managed inventory storage of Marburg monovalent vaccine under the Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP) program.

The contract employs a hybrid cost reimbursement and fixed-price structure. BARDA will invest Project BioShield funds. The award was made without a set-aside.

Notice text

This acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV monovalent vaccine.

This contract was awarded on a hybrid cost reiumbursement/fixed price basis as circumstances do not allow the agency to define its requirements sufficiently to allow for a fixed-price type contract.

Awarded contract 75A50126C00001 to ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) for 1042099118.00 on 2026-05-05.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity